Figure 1.
Detection of sub-clonal mutations in the Abl gene. Top panel: Next-generation sequencing of the Abl gene in a CML patient results in thousands of artifactual errors, preventing detection of low-level mutations. Bottom panel: Duplex Sequencing of the same sample eliminates artifactual errors, revealing a single point mutation in Abl. This mutation (E279K) confers resistance to imatinib.